Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0014 | 0.0456 | 0.1714 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0046 | 0.259 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0038 | 0.2025 | 0.2025 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0103 | 0.6371 | 0.6371 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0103 | 0.6371 | 0.6371 |
Schistosoma mansoni | hypothetical protein | 0.0018 | 0.067 | 0.067 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0014 | 0.0456 | 0.1714 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0046 | 0.259 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.2025 | 0.2025 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0018 | 0.067 | 0.067 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0063 | 0.3708 | 0.3708 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0124 | 0.7728 | 1 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0158 | 1 | 1 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0158 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0014 | 0.0456 | 0.1714 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0018 | 0.067 | 0.067 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0016 | 0.0548 | 0.0548 |
Schistosoma mansoni | hypothetical protein | 0.0018 | 0.067 | 0.067 |
Loa Loa (eye worm) | acetyltransferase | 0.0158 | 1 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0009 | 0.0106 | 0.0106 |
Leishmania major | hypothetical protein, conserved | 0.0058 | 0.3363 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0058 | 0.3363 | 1 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0014 | 0.0456 | 0.1714 |
Schistosoma mansoni | cpg binding protein | 0.0063 | 0.3708 | 0.3708 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.002 | 0.0804 | 0.0804 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0046 | 0.259 | 0.2668 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0014 | 0.0456 | 0.1714 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0103 | 0.6371 | 0.6564 |
Onchocerca volvulus | 0.0063 | 0.3708 | 0.5 | |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0058 | 0.3363 | 0.1504 |
Schistosoma mansoni | hypothetical protein | 0.0018 | 0.067 | 0.067 |
Schistosoma mansoni | cpg binding protein | 0.0067 | 0.3948 | 0.3948 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.067 | 0.067 |
Echinococcus multilocularis | GPCR, family 2 | 0.0018 | 0.067 | 0.067 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0014 | 0.0456 | 0.1714 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0014 | 0.0456 | 0.1714 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0043 | 0.2333 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0103 | 0.6371 | 0.6371 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0056 | 0.3193 | 0.3193 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0058 | 0.3363 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0058 | 0.3363 | 0.5 |
Echinococcus multilocularis | cpg binding protein | 0.0067 | 0.3948 | 0.3948 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0056 | 0.3193 | 0.3193 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0103 | 0.6371 | 0.6371 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0016 | 0.0548 | 0.0564 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0058 | 0.3363 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0018 | 0.067 | 0.067 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0018 | 0.067 | 0.067 |
Echinococcus granulosus | GPCR family 2 | 0.0018 | 0.067 | 0.0691 |
Schistosoma mansoni | hypothetical protein | 0.0026 | 0.1234 | 0.1234 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0026 | 0.1234 | 0.1234 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0103 | 0.6371 | 0.6371 |
Brugia malayi | hypothetical protein | 0.0038 | 0.1995 | 0.1995 |
Echinococcus granulosus | cpg binding protein | 0.0067 | 0.3948 | 0.4068 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0016 | 0.0548 | 0.0548 |
Echinococcus granulosus | mixed lineage leukemia protein mll | 0.0016 | 0.0548 | 0.0564 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0014 | 0.0456 | 0.1714 |
Trichomonas vaginalis | helicase, putative | 0.0014 | 0.0456 | 0.1714 |
Schistosoma mansoni | hypothetical protein | 0.0018 | 0.067 | 0.067 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0014 | 0.0456 | 0.1714 |
Schistosoma mansoni | cpg binding protein | 0.0067 | 0.3948 | 0.3948 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0154 | 0.9706 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0103 | 0.6371 | 0.6371 |
Echinococcus multilocularis | mixed lineage leukemia protein mll | 0.0016 | 0.0548 | 0.0548 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0014 | 0.0456 | 0.1714 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0056 | 0.3193 | 0.3193 |
Brugia malayi | CXXC zinc finger family protein | 0.0063 | 0.3708 | 0.3708 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0014 | 0.0456 | 0.1714 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0014 | 0.0456 | 0.1714 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.3363 | 0.3363 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.002 | 0.0804 | 0.0829 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0014 | 0.0456 | 0.1714 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.3193 | 0.3193 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0018 | 0.067 | 0.0691 |
Brugia malayi | hypothetical protein | 0.0058 | 0.3363 | 0.3363 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0103 | 0.6371 | 0.6371 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0134 | 0.8423 | 0.8423 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0014 | 0.0456 | 0.1714 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0026 | 0.1234 | 0.1272 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0043 | 0.2333 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0058 | 0.3363 | 0.5 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0018 | 0.067 | 0.0691 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0014 | 0.0456 | 0.1714 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0014 | 0.0456 | 0.1714 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0058 | 0.3363 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0103 | 0.6371 | 0.6564 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0014 | 0.0456 | 0.1714 |
Loa Loa (eye worm) | histone methyltransferase | 0.002 | 0.0804 | 0.0804 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0018 | 0.067 | 0.067 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.2025 | 0.2025 |
Brugia malayi | F/Y-rich N-terminus family protein | 0.0019 | 0.0788 | 0.0788 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 7 | Compound tested for hallucinogenic activity in humans was reported; Value reported in (A)= Mescaline units | ChEMBL. | 9748359 |
Activity (functional) | = 7 | Compound tested for hallucinogenic activity in humans was reported; Value reported in (A)= Mescaline units | ChEMBL. | 9748359 |
Activity (functional) | = 6 MU | Hallucinogenic activity i.e; ratio of effective dose of mescaline to the effective dose of the compound was determined in human | ChEMBL. | 2299636 |
Activity (functional) | = 6 MU | Hallucinogenic activity i.e; ratio of effective dose of mescaline to the effective dose of the compound was determined in human | ChEMBL. | 2299636 |
Log activity (functional) | = 0.778 | Log value of hallucinogenic activity was determined | ChEMBL. | 2299636 |
Relative activity (functional) | = 10 | Psychotomimetic potency of compound relative to that of mescaline (Human potency of mescaline = 1 MU) | ChEMBL. | 6737431 |
Relative activity (functional) | = 10 | Psychotomimetic potency of compound relative to that of mescaline (Human potency of mescaline = 1 MU) | ChEMBL. | 6737431 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
3 literature references were collected for this gene.